| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4292912
[patent_doc_number] => 06235796
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-22
[patent_title] => 'Use of fluorocarbons for the prevention of surgical adhesions'
[patent_app_type] => 1
[patent_app_number] => 9/603285
[patent_app_country] => US
[patent_app_date] => 2000-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1908
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/235/06235796.pdf
[firstpage_image] =>[orig_patent_app_number] => 603285
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/603285 | Use of fluorocarbons for the prevention of surgical adhesions | Jun 25, 2000 | Issued |
| 60/304189 | Subtype selective melatonergics | Jun 22, 2000 | Pending |
Array
(
[id] => 4314337
[patent_doc_number] => 06242436
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-05
[patent_title] => 'Use of 5alpha-androstanediol or 5alpha-androstanedione to increase dihydrotestosterone levels in humans'
[patent_app_type] => 1
[patent_app_number] => 9/594569
[patent_app_country] => US
[patent_app_date] => 2000-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1546
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/242/06242436.pdf
[firstpage_image] =>[orig_patent_app_number] => 594569
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/594569 | Use of 5alpha-androstanediol or 5alpha-androstanedione to increase dihydrotestosterone levels in humans | Jun 14, 2000 | Issued |
| 09/588481 | Method for treating patients with macular degeneration by administering substituted sulfonyl indenyl acetic acids and alcohols | Jun 5, 2000 | Abandoned |
| 09/555911 | PHARMACEUTICAL COMPOSITION FOR TREATING CEREBRAL APOPLEXY AND CRANIOCEREBRAL TRAUMA | Jun 5, 2000 | Abandoned |
Array
(
[id] => 1037590
[patent_doc_number] => 06872739
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-29
[patent_title] => 'Use of riluzole for the treatment of multiple sclerosis'
[patent_app_type] => utility
[patent_app_number] => 09/926693
[patent_app_country] => US
[patent_app_date] => 2000-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2993
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/872/06872739.pdf
[firstpage_image] =>[orig_patent_app_number] => 09926693
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/926693 | Use of riluzole for the treatment of multiple sclerosis | Jun 1, 2000 | Issued |
Array
(
[id] => 4314521
[patent_doc_number] => 06242446
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-05
[patent_title] => 'Method for treating attention deficit disorder'
[patent_app_type] => 1
[patent_app_number] => 9/583611
[patent_app_country] => US
[patent_app_date] => 2000-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17856
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 871
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/242/06242446.pdf
[firstpage_image] =>[orig_patent_app_number] => 583611
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/583611 | Method for treating attention deficit disorder | May 30, 2000 | Issued |
Array
(
[id] => 1535048
[patent_doc_number] => 06489341
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-03
[patent_title] => 'Methods for the treatment of neuroleptic and related disorders using sertindole derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/580492
[patent_app_country] => US
[patent_app_date] => 2000-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9548
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/489/06489341.pdf
[firstpage_image] =>[orig_patent_app_number] => 09580492
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/580492 | Methods for the treatment of neuroleptic and related disorders using sertindole derivatives | May 29, 2000 | Issued |
| 09/571962 | Use of amino-isoxazolidone compounds for improvement of implicit memory | May 15, 2000 | Abandoned |
Array
(
[id] => 1475284
[patent_doc_number] => 06387957
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-14
[patent_title] => 'Preparation of topical regional compositions for the relief of pain'
[patent_app_type] => B1
[patent_app_number] => 09/569515
[patent_app_country] => US
[patent_app_date] => 2000-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5730
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/387/06387957.pdf
[firstpage_image] =>[orig_patent_app_number] => 09569515
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/569515 | Preparation of topical regional compositions for the relief of pain | May 11, 2000 | Issued |
Array
(
[id] => 4269915
[patent_doc_number] => 06306908
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-23
[patent_title] => 'Methods for reducing the incidence of necrotizing enterocolitis'
[patent_app_type] => 1
[patent_app_number] => 9/570299
[patent_app_country] => US
[patent_app_date] => 2000-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8236
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/306/06306908.pdf
[firstpage_image] =>[orig_patent_app_number] => 570299
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/570299 | Methods for reducing the incidence of necrotizing enterocolitis | May 11, 2000 | Issued |
| 09/567379 | USE OF 5ALPHA-ANDROST-1-EN-3,17-DIONE TO INCREASE THE LEVEL OF THE ANABOLIC/ANDROGENIC HORMONE 17BETA-HYDROXY-5ALPHA-ANDROST-1-EN-3-ONE IN HUMANS | May 9, 2000 | Abandoned |
Array
(
[id] => 4338318
[patent_doc_number] => 06333356
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-25
[patent_title] => 'Compounds for treating skin conditions'
[patent_app_type] => 1
[patent_app_number] => 9/566556
[patent_app_country] => US
[patent_app_date] => 2000-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7010
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/333/06333356.pdf
[firstpage_image] =>[orig_patent_app_number] => 566556
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/566556 | Compounds for treating skin conditions | May 7, 2000 | Issued |
| 09/563902 | Method of treating paralysis of the extremities caused by cerebral infarction | May 3, 2000 | Abandoned |
Array
(
[id] => 4409940
[patent_doc_number] => 06265414
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-24
[patent_title] => 'Treating sleep disorders using desloratadine'
[patent_app_type] => 1
[patent_app_number] => 9/563553
[patent_app_country] => US
[patent_app_date] => 2000-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1820
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/265/06265414.pdf
[firstpage_image] =>[orig_patent_app_number] => 563553
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/563553 | Treating sleep disorders using desloratadine | May 2, 2000 | Issued |
Array
(
[id] => 7607502
[patent_doc_number] => 07098214
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-08-29
[patent_title] => 'Dopamine D3 receptor ligands or antagonists for use in the treatment of renal function disorders'
[patent_app_type] => utility
[patent_app_number] => 09/959787
[patent_app_country] => US
[patent_app_date] => 2000-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6341
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/098/07098214.pdf
[firstpage_image] =>[orig_patent_app_number] => 09959787
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/959787 | Dopamine D3 receptor ligands or antagonists for use in the treatment of renal function disorders | Apr 27, 2000 | Issued |
Array
(
[id] => 4409289
[patent_doc_number] => 06239162
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-29
[patent_title] => 'Method for treating depression'
[patent_app_type] => 1
[patent_app_number] => 9/559609
[patent_app_country] => US
[patent_app_date] => 2000-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3982
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/239/06239162.pdf
[firstpage_image] =>[orig_patent_app_number] => 559609
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/559609 | Method for treating depression | Apr 26, 2000 | Issued |
| 09/557954 | Method of treatment | Apr 23, 2000 | Abandoned |
Array
(
[id] => 4410211
[patent_doc_number] => 06228843
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-08
[patent_title] => 'Method of using PKC inhibiting compounds to treat vascular disease'
[patent_app_type] => 1
[patent_app_number] => 9/557038
[patent_app_country] => US
[patent_app_date] => 2000-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 7395
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/228/06228843.pdf
[firstpage_image] =>[orig_patent_app_number] => 557038
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/557038 | Method of using PKC inhibiting compounds to treat vascular disease | Apr 20, 2000 | Issued |
Array
(
[id] => 4304932
[patent_doc_number] => 06251930
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-26
[patent_title] => 'Activating C1- secretion'
[patent_app_type] => 1
[patent_app_number] => 9/529915
[patent_app_country] => US
[patent_app_date] => 2000-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 32
[patent_no_of_words] => 5669
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/251/06251930.pdf
[firstpage_image] =>[orig_patent_app_number] => 529915
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/529915 | Activating C1- secretion | Apr 20, 2000 | Issued |